dc.contributorUniversidade do Estado do Rio de Janeiro (UERJ)
dc.contributorFIOCRUZ
dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.creatorGuimaraes, M. L.
dc.creatorBastos, F. I.
dc.creatorTelles, P. R.
dc.creatorGalvao-Castro, B.
dc.creatorDiaz, R. S.
dc.creatorBongertz, V
dc.creatorMorgado, M. G.
dc.date.accessioned2016-01-24T12:31:23Z
dc.date.accessioned2023-09-04T18:20:09Z
dc.date.available2016-01-24T12:31:23Z
dc.date.available2023-09-04T18:20:09Z
dc.date.created2016-01-24T12:31:23Z
dc.date.issued2001-05-01
dc.identifierJournal of Clinical Virology. Amsterdam: Elsevier B.V., v. 21, n. 2, p. 143-151, 2001.
dc.identifier1386-6532
dc.identifierhttp://repositorio.unifesp.br/handle/11600/26544
dc.identifier10.1016/S1386-6532(01)00158-5
dc.identifierWOS:000168906900005
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8613316
dc.description.abstractBackground: Retrovirus infections among injecting drug users (IDUs), a core at-risk population for both HIV-1 and HTLV-I/II infections in Brazil, were assessed within an ongoing cooperative research. Objective: the study assessed the seroprevalences of HIV-1 and HTLV-I/II infections, as well as the prevalence of HIV-1 subtypes in a sample of IDUs from Rio de Janeiro, Brazil. An attempt to evaluate HIV incidence was carried out using a dual 'sensitive/less sensitive' testing strategy. Study design: Cross-sectional evaluation of 175 IDUs. Serostatus for HIV-1 and HTLV-I,II were established by enzyme-linked immunosorbent assays, and confirmed by western blot. the dual testing strategy aimed to estimate HIV-1 incidence rates. Differentiation between HTLV-I and -II was performed by western blot. DNA samples were polymerase chain reaction amplified by a nested protocol, and HIV-1 subtyping was determined by heteroduplex mobility assay. Results: Forty-six and 29 samples were found to be, respectively, positive for HIV-1 and HTLV-I/II, 15 of them co-infected by both viruses. Among HTLV-I/II-infected patients, 75.9% were infected by HTLV-I. Thirty-one HIV samples were identified as B subtype, with seven of them showing the typical 'Brazilian B' pattern in the gp120 V3 loop, and ten were identified as F subtype. the use of less sensitive assays for HIV infection wrongly identified a deeply immunocompromised patient as an incident case. Conclusion: Moderately high seroprevalences were found for both HIV-1 and HTLV-I/II infections, HIV-1/HTLV-I co-infections being of special concern. A non-statistically significant higher prevalence of F subtype was observed, when compared with the distribution of F/B subtypes among Brazilian patients from other exposure categories. No recent HIV-1 infections were detected, but a limitation of the 'sensitive/less-sensitive' testing strategy was made evident. (C) 2001 Elsevier Science B.V. All rights reserved.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationJournal of Clinical Virology
dc.rightshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.rightsAcesso restrito
dc.subjectinjecting drug users
dc.subjectHIV
dc.subjectHTLV
dc.subjectHIV/HTLV co-infection
dc.subjectsensitive/less sensitive dual testing strategy for HIV infection
dc.titleRetrovirus infections in a sample of injecting drug users in Rio de Janeiro City, Brazil: prevalence of HIV-1 subtypes, and co-infection with HTLV-I/II
dc.typeArtigo


Este ítem pertenece a la siguiente institución